Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.

426 F. App'x 904
Court of Appeals for the Federal Circuit·Decided July 21, 2011·No. No. 2009-1593·Published

Opinion

ORDER

Upon consideration of the order of the Supreme Court of the United States in Eisai Co., Ltd., et al. v. Teva Phamaceuticals USA, Inc. Through its Gate Pharmaceuticals Division, — U.S. -, 131 S.Ct. 2991, 180 L.Ed.2d 818 (2011), vacating this court’s judgment,

It is Ordered That:

(1) The mandate of this court issued on December 13, 2010 is recalled, the appeal is reinstated, and this court’s October 6, 2010 judgment is vacated.

(2) The appeal is remanded to the district court with instructions to dismiss the complaint as moot.

Free access — add to your briefcase to read the full text and ask questions with AI

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co., 426 F. App'x 904 (Fed. Cir. 2011).

426 F. App'x 904 (Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Eisai Co. v. Teva Pharmaceuticals USA, Inc.
180 L. Ed. 2d 818 (Supreme Court, 2011)